Childhood asthma and allergic rhinitis: The role of leukotrienes

Journal of Pediatrics

Volumn 131, Issue 3, 1997, Pages 348-355

  Rachelefsky, G ^a  

^a Allergy Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; ARACHIDONIC ACID; CROMOGLYCATE DISODIUM; LEUKOTRIENE; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NEDOCROMIL; PRANLUKAST; ZAFIRLUKAST; ZILEUTON;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHOSPASM; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; EXERCISE INDUCED ASTHMA; INFLAMMATION; LUNG FUNCTION; MAST CELL; MUCUS SECRETION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SAFETY; TREATMENT PLANNING;

EID: 0030724303     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)80057-1     Document Type: Article

References (66)

1. Cypcar D Busse WW Steroid-resistant asthma J Allergy Clin Immunol 92 1993 362 372
2. Feb Khunti K Issues in adolescent asthma: compliance Maternal Child Health 1996 36 38
3. Selcow JE Safety of bronchodilator therapy in pediatric asthma patients Clin Ther 16 1994 622 633
4. Doull IJM Freezer NJ Holgate ST Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate Am J Respir Crit Care Med 151 1995 1715 1719
5. Weinstein AG Clinical management strategies to maintain drug compliance in asthmatic children Ann Allergy Asthma Immunol 74 1995 304 310
6. (Suppl) Weeke ER Epidemiology of allergic diseases in children Rhmology 13 1992 5 12
7. Evans R Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis Middleton EJ Reed CE Ellis EF Adkinson NFJ Yunginger JW Busse WW Allergy principles and practice 4th ed 1993 Mosby-Year Book St Louis 1109 1156
8. Nelson HS The 1985 Bela Schick lecture: the atopic diseases Ann Allergy 55 1985 441 447
9. Booij-Noord H De Vries K Sluiter HJ Orie NGM Late bronchial obstructive reaction to experimental inhalation of house dust mite extract Clin Allergy 2 1972 43 61
10. Price IF Hey EN Spothill JF Antigen provocation to the skin, nose, and lung in children with asthma; immediate and dual hypersensitivity reaction Exp Immunol 47 1982 587 594
11. Warner JO Signficance of late reactions after bronchial challenge with house dust mite Arch Dis Child 51 1976 905 911
12. Dahlen S-E Hedqvist P Hammarstrom S Samuelsson B Leukotrienes are potent constrictors of human bronchi Nature 288 1980 484 486
13. Drazen JM Austen KF Lewis RA Clark DA Goto G Marfat A Comparative airway and vascular activities of leukotrienes C-l and D in vivo and in vitro Proc Natl Acad Sci U S A 77 1980 4354 4358
14. Drazen JM Leukotrienes in asthma and rhinitis Busse WW Asthma and rhinitis 1994 Blackwell Scientific Oxford
15. Rovati GE Giovanazzi S Mezzetti M Nicosia S Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma Biochem Pharmacol 44 1992 1411 1415
16. O'Donnell M Welton A Comparison of the pulmonary pharmacology of leukotrienes and PAF: effects of their antagonists Lewis AJ Doherty NS Ackeman NR Therapeutic approaches to inflammatory diseases 1989 Elsevier New York 169 193
17. 4 and the peptide leukotriene antagonist ICI-198615 to receptors on human lung membranes Zor U Naor Z Dranon A New trends in lipid mediators research 1989 Karger Basel 67 71
18. Drazen JM Comparative contractile responses to sulfidopeptide leukotrienes in normal and asthmatic human subjects Ann N Y Acad Sci 524 1988 289 297
19. 4 and leukotriene D J Pharmacol Exp Ther 237 1986 558 562
20. 4 on the microvasculature of guinea pigs Prostaglandins 21 1981 315 321
21. 4 on glycoprotein and lysozyme secretion by human bronchial mucosa Prostaglandins 25 1983 155 170
22. 4: comparison of potency in canine trachea in vivo Prostaglandins 25 1983 237 243
23. Yanni JM Foxwell MH Whitman LL Smith WL Nolan JC Effect of intravenously administered lipoxygenase metabolites on rat tracheal mucous gel layer thickness Int Arch Allergy Appl Immunol 90 1989 307 309
24. Hui KP Barnes NC Lung function improvement in asthma with a cystemylleukotriene receptor antagonist Lancet 337 1991 1062 1063
25. Israel E Rubin P Kemp J Grossman J Pierson W Siegel SC The effect of in-hibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma Ann Intern Med 119 1993 59 66
26. 4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence Blood 58 1981 658 663
27. 4 Br Med Bull 39 1983 249 254
28. Henderson WRJ Eicosanoids and lung inflammation Am Rev Respir Dis 135 1987 1176 1185
29. Henderson WR Klebanoff SJ Leukotriene production and inactivation by normal, chronic granulomatous disease, and myeloperoxidase-deficient neutrophils J Biol Chem 258 1983 13522 13527
30. 4 in bronchoalveolar lavage in bronchial asthma and other diseases J Allergy Clin Immunol 84 1989 19 26
31. Pipkorn U Proud D Lichtenstein LM Schleimer RP Peters SP Adkinson NF Jr Effect of short-term systemic gluco-corticoid treatment on human nasal media-tor release after antigen challenge J Clin Invest 80 1987 957 961
32. Knani J Campbell A Enander I Peterson CG Michel F-B Bousquet J Indirect evi-dence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic J Allergy Clin Immunol 90 1992 880 889
33. 4 from the urine of patients with airway obstruction Am Rev Respir Dis 146 1992 104 108
34. Wang D Clement P Smitz J Derde MP Concentrations of chemical mediators m nasal secretions of patients with hay fever during natural allergen exposure Acta Otolaryngol 114 1994 552 555
35. 4 in humans: effect of indomethacin Am Rev Respir Dis 141 1990 1441 1445
36. 4 concentrations increase after aspirin challenge in aspirin-sensitive asth-matic subjects Am J Respir Dis 143 1991 1025 1029
37. Ferreri NR Howland WC Stevenson DD Spiegelberg HL Release of leukotrienes prostaglandins,and histamine into nasal se-cretions of aspirin-sensitive asthmatics dur-ing reaction to aspirin Am Rev Respir Dis 137 1988 847 854
38. Iikura Y Nagakura T Walsh GM Akimoto K Kisida M Kondou T Role of chem-ical mediators after antigen and exercise challenge in children with asthma J Allergy Clin Immunol 81 1988 1050 1055
39. Broide DH Eisman S Ramdel JW Ferguson P Schwartz LB Wasserman S Airway levels of mast cell derived mediators in exercise induced asthma Am Rev Respir Dis 141 1990 563 568
40. Pliss LB Ingenito EP Ingram RHJ Pichurko B Assessment of bronchoalveolar cell and mediator response to isocapnic hy-perpnoea in asthma Am Rev Respir Dis 142 1990 73 78
41. Israel E Dermarkarian R Rosenberg M Sperling R Taylor G Rubin P The ef-fects of a 5-lipoxygenase inhibitor on asthma induced by cold dry air N Engl J Med 323 1990 1769 1770
42. 4 antag-onist Am Rev Respir Dis 145 1992 746 749
43. Robuschi M Riva E Fuccella WM Vida E Barnabe R Rossi M Prevention of ex-ercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104 353) : a double-blind study versus disodium cromo-glycate and Am Rev Respir Dis 145 1992 1285 1288
44. Busse WW Gaddy JN The role of leukotriene antagonists and inhibitors in the treatment of airway disease Am Rev Respir Dis 143 1991 S103 S107
45. Diamant Z Lammers J-WJ Sterk PJ Leukotriene receptor antagonists and bio-synthesis inhibitors in asthma Clin Immuno-therapeutics 2 1904 220 232
46. Hui KP Comment: leukotriene antagonists and synthesis inhibitors: just about to prove their worth? Curr Med Literature 6 1992 87 92
47. McMillan RM Inhibitors of leukotriene synthesis and actions: Asthma drugs of the near future? Langer SZ Church MK Vergaftig EB Nicosia S New developments in the therapy of allergic disorders and asthma 1993 S. Karger Farmington (CT) 71 85
48. 4 receptor antagonist ICI 204,219 Am Rev Respir Dis 141 1990 988 992
49. 4-induced bronchoconstriction in the human Am Rev Respir Dis 144 1991 617 621
50. Dahlen B Zetterström O Björck T Dahlén S-E The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics Eur Respir J 7 1994 324 331
51. Malo PE Bell RL Shaughnessy TK Summers JB Brooks DW Carter GW The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis Puhn Pharmacol 7 1994 73 79
52. Knapp HR Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor N Engl J Med 323 1990 1745 1748
53. Hui K Taylor I Taylor G Rubin P Kesterson J Barnes NC Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients Thorax 46 1991 184 189
54. 4-receptor an-tagonist ICI 204219 relieves symptoms of acute seasonal allergic rhinitis Am J Respir Crit Care Med 151 1995 1734 1739
55. Kawabori I Pierson WE Conquest LL Bierman CW Incidence of exercise induced asthma in children J Allergy Clin Immunol 58 1976 447 455
56. Serra-Batlles J Montserrat JM Mullol J Ballester E Xaubet A Picado C Response of the nose to exercise m healthy subjects and m patients with rhinitis and asthma Thorax 49 1994 128 132
57. Kemp JP Dockhorn RJ Shapiro GG Nguyen HH Guerreiro DA Reiss TF Montelukast, a leukotriene receptor antagonist, inhibits exercise-induced bronchoconstriction in 6-to 14-year-old children [abstract] J Allergy Clin Immunol 99 1997 S321
58. 4 and histamine m asthmatics Am Rev Respir Dis 146 1992 96 103
59. Yamamoto H Nagata M Kuramitsu K Kiuchi H Sakamoto Y Yamamoto K Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078 Am J Respir Crit Care Med 150 1994 254 257
60. Nathan RA Glass M Snader L Effects of 13 weeks of treatment with ICI 204 219 (‘Accolate’) or cromolyn sodium (‘Intal’) in patients with mild to moderate asthma [ab-stract] J Allergy Clin Immunol 95 1995 388
61. Knorr BA Matz J Bernstein JA Becker A Reiss T Erickson U Montelukast (MK-0476) improves asthma over a month treatment period in 6-to 14-year-olds [abstract] Am J Respir Crit Care Med 155 1997 A664
62. 4 re-ceptor antagonist in subjects with bron-chial asthma Am J Respir Crit Care Med 150 1994 618 623
63. Spector S Miller CJ Glass M 13-week dose-response study with Accolate (zafir-lukast) in patients with mild-to-moderate asthma [abstract] Am J Respir Crit Care Med 151 1995 A379
64. Lockey RF Lavins BJ Snader L Effects of 13 weeks of treatment with ICI 204 219 (Accolate) in patients with mild-to-moder-ate asthma [abstract] J Allergy Clin Immunol 95 1995 350
65. SCRIP World Pharmaceutical News 2017 1995 29 30
66. Chen X-S Sheller JR Johnson EN Funk CD Role of leukotrienes revealed by tar-geted disruption of the 5-lipoxygenase gene Nature 372 1994 179 182